Literature DB >> 20621054

An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity.

Kristin J Hope1, Sonia Cellot, Stephen B Ting, Tara MacRae, Nadine Mayotte, Norman N Iscove, Guy Sauvageau.   

Abstract

In this study, we describe an in vivo RNA interference functional genetics approach to evaluate the role of 20 different conserved polarity factors and fate determinants in mouse hematopoietic stem cell (HSC) activity. In total, this screen revealed three enhancers and one suppressor of HSC-derived reconstitution. Pard6a, Prkcz, and Msi2 shRNA-mediated depletion significantly impaired HSC repopulation. An in vitro promotion of differentiation was observed after the silencing of these genes, consistent with their function in regulating HSC self-renewal. Conversely, Prox1 knockdown led to in vivo accumulation of primitive and differentiated cells. HSC activity was also enhanced in vitro when Prox1 levels were experimentally reduced, identifying it as a potential antagonist of self-renewal. HSC engineered to overexpress Msi2 or Prox1 showed the reverse phenotype to those transduced with corresponding shRNA vectors. Gene expression profiling studies identified a number of known HSC and cell cycle regulators as potential downstream targets to Msi2 and Prox1. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621054     DOI: 10.1016/j.stem.2010.06.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  68 in total

1.  A cancer fate in the hands of a samurai.

Authors:  Malcolm A S Moore
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

Review 2.  Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.

Authors:  Melanie C MacNicol; Chad E Cragle; Angus M MacNicol
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

3.  Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

Authors:  Bing Z Carter; Yihua Qiu; Xuelin Huang; Lixia Diao; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Marina Konopleva; Jorge Cortes; Hagop M Kantarjian; Gordon B Mills; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2012-05-29       Impact factor: 22.113

4.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Authors:  Sun-Mi Park; Mithat Gönen; Ly Vu; Gerard Minuesa; Patrick Tivnan; Trevor S Barlowe; James Taggart; Yuheng Lu; Raquel P Deering; Nir Hacohen; Maria E Figueroa; Elisabeth Paietta; Hugo F Fernandez; Martin S Tallman; Ari Melnick; Ross Levine; Christina Leslie; Christopher J Lengner; Michael G Kharas
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

5.  Msi2 Maintains Quiescent State of Hair Follicle Stem Cells by Directly Repressing the Hh Signaling Pathway.

Authors:  Xianghui Ma; Yuhua Tian; Yongli Song; Jianyun Shi; Jiuzhi Xu; Kai Xiong; Jia Li; Wenjie Xu; Yiqiang Zhao; Jianwei Shuai; Lei Chen; Maksim V Plikus; Christopher J Lengner; Fazheng Ren; Lixiang Xue; Zhengquan Yu
Journal:  J Invest Dermatol       Date:  2017-01-29       Impact factor: 8.551

6.  RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.

Authors:  Sonia Cellot; Kristin J Hope; Jalila Chagraoui; Martin Sauvageau; Éric Deneault; Tara MacRae; Nadine Mayotte; Brian T Wilhelm; Josette R Landry; Stephen B Ting; Jana Krosl; Keith Humphries; Alexander Thompson; Guy Sauvageau
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

7.  The ERGonomics of hematopoietic stem cell self-renewal.

Authors:  Scott A Lacadie; Leonard I Zon
Journal:  Genes Dev       Date:  2011-02-15       Impact factor: 11.361

8.  Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation.

Authors:  Amitava Sengupta; Angeles Duran; Eri Ishikawa; Maria Carolina Florian; Susan K Dunn; Ashley M Ficker; Michael Leitges; Hartmut Geiger; Maria Diaz-Meco; Jorge Moscat; Jose A Cancelas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-08       Impact factor: 11.205

9.  RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia.

Authors:  Ayuna Hattori; Daniel McSkimming; Natarajan Kannan; Takahiro Ito
Journal:  Leuk Res       Date:  2017-01-11       Impact factor: 3.156

10.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.